Notes in Medulloblastoma

To Subscribe, use this Key


Status Last Update Fields
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 1.2 | Epidemiology
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 1.1 | Definition
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 1.3 | Risk factors
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 1.3.1 | Gorlin Syndrome
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 1.4.1 | Pathology
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 1.5 | Biologic behaviour
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 1.6.1 | DDx of a posterior fossa mass
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 1.7 | Clinical presentation
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 2.1 | Workup
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 2.2 | Prognostic factors
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 2.4 | Staging
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 3.1 | Management overview
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 3.2 | Immediate management
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 3.3 | Surgery
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 3.4 | Radiotherapy
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 3.5 | Chemotherapy
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 3.6 | <3yo patients
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 3.7 | Recurrent disease
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 3.8 | Follow up
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 3.9 | Outcomes
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 4 | Emerging therapies: SHH pathway inhibition
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 5 | RT technique
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 1.6.2 | Atypical teratoid rhabdoid tumour (ATRT)
Published 02/18/2024 Paeds | CNS | Medulloblastoma | 2.3 | Prognostic factors | Genetically defined Molecular Groups
Status Last Update Fields